Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000120.xml
DO - Deutsche Zeitschrift für Osteopathie 2024; 22(02): 34-41
DOI: 10.1055/a-2220-8344
DOI: 10.1055/a-2220-8344
Spektrum interdisziplinär
Osteopathie und evidenzbasierte Medizin, Teil 2: Kritik an der EBM
Zusammenfassung
Die EBM ist bestrebt, die Medizin stetig zu verbessern [1]. Aus allen uns zur Verfügung stehenden Quellen sollen Entscheidungen zu einzelnen medizinischen Fragestellungen nach den besten vorliegenden Belegen getroffen werden [2]. Der Patient steht dabei immer im Zentrum aller Überlegungen [3]. Das klingt doch toll! Aber warum tun wir uns so schwer mit der EBM? Warum rufen wir in der Osteopathie nicht „Hurra!“? Stattdessen müssen wir uns wiederholt dafür rechtfertigen, wenn wir in der osteopathischen Community über EBM sprechen wollen? [4] Wie kann das sein?
Publication History
Article published online:
27 March 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Guyatt G, Rennie D, Meade MO. et al Users’ guides to the medical literature: a manual for evidence based clinical practice. 3. Aufl. New York: McGraw-Hill Education; 2015
- 2 Sackett DL, Rosenberg W, Mc Gray JA. et al. Evidence-based medicine: what it is and what it isn’t. BMJ 1996; 312: 71-72
- 3 Haynes RB, Devereaux PJ, Guyatt GH. Clinical expertise in the era of evidencebased medicine and patient choice. Editorial ACP J Club 2002; 136: A11-14
- 4 Humpage C. Opinions on research and evidence based medicine within the UK osteopathic profession: A thematic analysis of public documents 2003–2009. IJOM 2011; 14: 48-56
- 5 Semrau F, Aidelsburger P, Israel CW. Common misunderstandings of evidence-based medicine. Herzschr Elektrophys 2023; 34: 232-239
- 6 Straus S, Haynes B, Glasziou P. et al. Misunderstandings, misperceptions, and mistakes. ACP J Club 2007; 146: A8-9
- 7 Haynes RB, Sackett DL, Gray JM. et al. Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. ACP J Club 1996; 125: A14-16
- 8 Sackett DL, Rosenberg WMC, Gray JAM. et al. Was ist Evidenz-basierte Medizin und was nicht?. Münch med Wschr 1997; 139: 644-645
- 9 Bölter R, Kühlein T, Ose D. et al. Barriers to evidence-based medicine encountered among GPs – an issue based on misunderstanding? A qualitative study in the general practice setting. Zeitschrift für Evidenz, Fortbildung und Qualität im. Gesundheitswesen 2010; 104: 661-666
- 10 Smith R, Rennie D. Evidence-Based Medicine—an oral History. JAMA 2014; 311: 365-367
- 11 Guyatt GH, Oxman AD, Schünemann HJ. et al. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011; 64: 380-382
- 12 Greenhalgh T, Howick J. Maskrey N for the Evidence Based Medicine Renaissance Group Evidence based medicine: a movement in crisis?. BMJ 2014; 348: g3725
- 13 https://ebmlive.org/reasons Stand: 11.09.2023
- 14 Glaziou P, Chalmers I. Research waste is still a scandal—an essay. BMJ 2018; 363: k4645
- 15 Altman DG. The scandal of poor medical research. BMJ 1994; 308: 283-284
- 16 Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet 2009; 374: 86-89
- 17 Schor S, Karten I. Statistical evaluation of medical journal manuscripts. JAMA 1966; 195: 1123-1128
- 18 Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature 2012; 483: 531-533
- 19 Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2: e124
- 20 Freedman LP, Gibson MC. The impact of preclinical irreproducibility on drug development. Clin Pharmacol Ther 2015; 97: 16-18
- 21 Baker M. 1500 scientists lift the lid on reproducibility. Nature 2016; 533: 452-454
- 22 Hartshorne JK, Schachner A. Tracking replicability as a method of post-publication open evaluation. Front Comput Neurosci 2012; 6: 8
- 23 Begley C, Ellis L. Raise standards for preclinical cancer research. Nature 2012; 483: 531-533
- 24 Freedman LP, Venugopalan G, Wisman R. Reproducibility 2020: Progress and priorities. F1000Res 2017; 6: 604
- 25 Christakis DA, Zimmerman FJ. Rethinking reanalysis. JAMA 2013; 310: 2499-2500
- 26 Steward O, Popovich PG, Dietrich WD. et al. Replication and reproducibility in spinal cord injury research. Exp Neurol 2012; 233: 597-605
- 27 Kimmelman J, Mogil JS, Dirnagl U. Distinguishing between exploratory and confirmatory preclinical research will improve translation. PLoS Biol 2014; 12: e1001863
- 28 Vasilevsky NA, Brush MH, Paddock H. et al. On the reproducibility of science: unique identification of research resources in the biomedical literature. PeerJ 2013; 1: e148
- 29 Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLOS Biol 2015; 13: e1002165
- 30 Peng Rzc. The Reproducibility Crisis in Science: A Statistical Counterattack. Significance 2015; 12: 30-32
- 31 Liang YL. Wissenschaft in der Krise? Beiträge zur Untersuchung von Fehlverhalten in der wissenschaftlichen Forschung. Dissertation, Fachbereichs Philosophie, Universität Trier 2007 https://ubt.opus.hbz-nrw.de/opus45-ubtr/frontdoor/deliver/index/docId/290/file/faelschung_1.pdf Stand: 11.09.2023
- 32 Wallach JD, Boyack KW, Ioannidis JPA. Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017. PLoS Biol 2018; 16: e2006930
- 33 Finetti M. https://www.abendblatt.de/archiv/2000/article204289931/Die-Task-Force-der-DFG-hat-eine-Bilanz-des-groessten-Faelschungsskandals-in-der-deutschen-Wissenschaft-gezogen-Die-Krebsforscher-Friedhelm-Herrmann-und-Marion-Brach-haben-weit-mehr-manipuliert-als-bislang-bekannt-war.html Stand: 11.08.2023
- 34 Fanelli D. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One 2009; 4: e5738
- 35 Goodman SN. Of P-Values and Bayes: A Modest Proposal. Epidemiology 2001; 12: 295-297
- 36 Matthews DR, McPherson K. Doctors̓ ignorance of statistics. Br Med J (Clin Res Ed). 1987. 294. 856-857
- 37 Jung I. Some Facts That You Might Be Unaware of About the P-Value. Arch Plast Surg 2017; 44: 93-94
- 38 Nuzzo R. Statistical errors. P values, the ‘gold standard’ of statistical validity, are not as reliable as many scientists assume. Nature 2014; 506: 150-152
- 39 Wasserstein RL, Lazar NA. The ASA’s statement on p-values: context, process, and purpose. The American Statistician 2016; 70: 129-133
- 40 Matthews R. The ASA̓s p-value statement, one year on. Significance 2017; 14: 38-41
- 41 Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond ‘p<0.05’. The American Statistician 2019; 73: 1-19
- 42 Hurlbert SH, Levine RA, Utts J. Coup de Grâce for a Tough Old Bull: “Statistically Significant“. The American Statistician 2019; 73: 352-357
- 43 Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature 2019; 567: 305-307
- 44 Benjamini Y, De Veaux RD, Efron B. et al. The ASA president’s task force statement on statistical significance and replicability. Ann. Appl Stat 2021; 15: 1084-1085
- 45 Ioannidis JPA. What have we (not) learned from millions of scientific papers with p values?. The American Statistician 2019; 73: 20-25
- 46 Simmons JP, Nelson LD, Simonsohn U. False-Positive Psychology: Undisclosed Flexibility in Data Collection and Analysis Allows Presenting Anything as Significant. Psychol Sci 2011; 22: 1359-1366
- 47 Head ML, Holman L, Lanfear R. et al. The extent and consequences of p-hacking in science. PLoS Biol 2015; 13: e1002106
- 48 Rosenthal R. File Drawer Problem and Tolerance for Null Results. Psychological Bulletin 1979; 86: 638-641
- 49 Krimsky S, Rothenberg LS, Stott P. et al Scientific journals and their authors’ financial interests: A pilot study. Psychother Psychosom 1998; 67: 194-201
- 50 Antes G. In: Homöopathie – Heilung oder Humbug. Buch und Regie: Carsten Binsack. Sendung auf 3sat vom 21.03.2013.
- 51 Osterloh F. Ökonomisierung der Medizin: Sinnentleerung ärztlichen Tuns. Dtsch Arztebl 2022; 119: A-1635
- 52 Maio G. Geschäftsmodell Gesundheit. Wie der Markt die Heilkunst abschafft. Berlin: Suhrkamp; 2014
- 53 Goldacre B. Die Pharma-Lüge. Wie Arzneimittelkonzerne Ärzte irreführen und Patienten schädigen. Köln: Kiepenheuer & Witsch; 2013
- 54 Leiß O. Kein L’art pour l’art, sondern zum Nutzen der Patienten. Dtsch Arztebl 2015; 112: A 130-132
- 55 Evidenzbasierte Medizin: Eine Strömung in der Krise? Übersetzung aus BMJ 2014; 348:g3725. Berliner Ärzte 2014; 51 (8): 20–22
- 56 Higgins JPT, Altman DG, Gøtzsche PC. et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928
- 57 Cohen D. FDA official: Clinical trial system is broken. BMJ 2013; 347: f6980
- 58 Every-Palmer S, Howick J. How evidence-based medicine is failing due to biased trials and selective publication. J Eval Clin Pract 2014; 20: 908-914
- 59 Blech J. Die Abschaffung der Gesundheit. Spiegel Politik. 2003 Stand: 11.09.2023
- 60 Burgmer M, Driesch G, Heuft G. Das “Sisi-Syndrom” – eine neue Depression?. Der Nervenarzt 2003; 74: 440-444
- 61 Bone HG, Greenspan SL, McKeever C. et al. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab 2000; 85: 720-726
- 62 Stone NJ, Robinson JG, Lichtenstein AH. et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 63. 2889-2934
- 63 Montori VM, Devereaux PJ, Adhikari NK. et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005; 294: 2203-2209
- 64 Talebi R, Redberg RF, Ross JS. Consistency of trial reporting between Clinical Trials.gov and corresponding publications: one decade after FDAAA. Trials 2020; 21: 675
- 65 Anderson ML, Chiswell K, Peterson ED. et al. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 2015; 372: 1031-1039
- 66 Song F, Parekh S, Hooper L. et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Assess 2010; 14 iii, ix–xi 1-193
- 67 Hopewell S, Loudon K, Clarke MJ. et al. Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev 2009; 2009: MR000006
- 68 Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 2008; 5: e191
- 69 Kessel M. Restoring the pharmaceutical industry’s reputation. Nat Biotechnol 2014; 32: 983-990
- 70 Doshi P. Pandemrix vaccine: why was the public not told of early warning signs?. BMJ 2018; 362: k3948
- 71 Brown SJ, Bakker CJ, Theis-Mahon NR. Retracted publications in pharmacy systematic reviews. J Med Libr Assoc 2022; 110: 47-55
- 72 Macleod MR, Michie S, Roberts I. et al. Biomedical research: increasing value, reducing waste. Lancet 2014; 383: 101-104
- 73 Retraction Watch. 2021 https://retractionwatch.com/retracted-coronavirus-covid-19-papers/ Stand: 11.09.2023
- 74 Ledford H, Van Noorden R. High-profile coronavirus retractions raise concerns about data oversight. Nature 2020; 582: 160
- 75 Trikalinos NA, Evangelou E, Ioannidis JP. Falsified papers in high-impact journals were slow to retract and indistinguishable from nonfraudulent papers. J Clin Epidemiol 2008; 61: 464-470
- 76 Steen RG. Retractions in the medical literature: how many patients are put at risk by flawed research?. J Med Ethics 2011; 37: 688-692
- 77 Bakker C, Riegelman A. Retracted publications in mental health literature: discovery across bibliographic platforms. J Librariansh Inf Sci 2018; 6 eP2199
- 78 Wes Brot. ich ess, des Lied ich sing: Die Kontamination der ärztlichen Fortbildung aus kritischer medizinjournalistischer Sicht. Der Arzneimittelbrief 2003; 37: 73
- 79 Lenzer J. Why we can't trust clinical guidelines. BMJ 2013; 346: f3830
- 80 Erklärung zu Interessenkonflikten in kardiovaskulären Leitlinien. Der Arzneimittelbrief 2011; 45: 34
- 81 Nejstgaard CH, Bero L, Hrobjartsson A. et al. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: Systematic review. BMJ 2020; 371: m4234
- 82 www.leitlinienwatch.de/?news=zahlungen-der-pharmaindustrie-an-leitlinienautoren-erkenntnisse-aus-dem-physician-payments-sunshine-act Stand: 11.09.2023
- 83 Napierala H, Schäfer L, Schott G. et al. Management of financial conflicts of interests in clinical practice guidelines in Germany: results from the public database GuidelineWatch. BMC Medical Ethics 2018; 19: 65
- 84 Bok D. Universities in the Marketplace: The Commercialization of Higher Education. Princeton und Oxford: Princeton University Press; 2003
- 85 Moynihan R, Albarqouni L, Nangla C. et al. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ 2020; 369: m1505
- 86 Schafer A. Biomedical conflicts of interest: A defense of the sequestration thesis. Learning from the cases of Nancy Olivieri and David Healy. J Med Ethics 2004; 30: 8-24
- 87 Moynihan R, Bero L, Hill S. et al. Pathways to independence: towards producing and using trustworthy evidence. BMJ 2019; 367: l6576
- 88 Taichman DB, Backus J, Baethge C. et al. A Disclosure Form for Work Submitted to Medical Journals – A Proposal from the International Committee of Medical Journal Editors. N Engl J Med. 2020. 382. 667-668
- 89 Howick J. Exploring the asymmetrical relationship between the power of finance bias and evidence. Perspect Biol Med 2019; 62: 159-187
- 90 Beerheide R, Lau T, Osterloh F. et al. Interview mit Prof. Dr. med. Jürgen Windeler, Leiter des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG): „Die evidenzbasierte Medizin hat einen zu kleinen Stellenwert. Dtsch Arztebl 2023; 120: A462-A464
- 91 Jureidini J, McHenry LB. The illusion of evidence based medicine. BMJ 2022; 376: o702
- 92 Greenhalgh T. Of lamp posts, keys, and fabled drunkards: A perspectival tale of 4 guidelines. J Eval Clin Pract 2018; 24: 1132-1138
- 93 Van de Vliet P, Sprenger T, Kampers LFC. et al. The Application of Evidence-Based Medicine in Individualized Medicine. Biomedicines 2023; 11: 1793
- 94 Krämer W. Fortschrittsfalle Medizin. Die Krankheit des Gesundheitswesens (IV) www.spiegel.de/politik/fortschrittsfalle-medizin-a-97208e6c-0002-0001-0000-000013493129M Stand: 11.09.2023
- 95 Tonelli M. The philosophical limits of evidence-based medicine. Acad Med 1999; 73: 1234-1240
- 96 Glasziou P, Moynihan R, Richards T. et al. Too much medicine; too little care. BMJ 2013; 347: f4247
- 97 Page L. Doctors’ dilemma: lower costs, please patients, or avoid lawsuits?. Medscape. www.medscape.com/viewarticle/829851 Stand: 11.09.2023
- 98 Bishop TF, Federman Ad, Keyhani S. Physician’s views on defensive medicine: a national survey. Arch Intern Med 2010; 170: 1081-1083
- 99 Hart D. Evidenz-basierte Medizin (EBM) und Gesundheitsrecht. Überlegungen zu rechtlichen Konsequenzen der Verwissenschaftlichung der Medizin. Medizinrecht 2000; 18: 1-5
- 100 Vogd W. Professionalisierungsschub oder Auflösung ärztlicher Autonomie. Die Bedeutung von Evidence Based Medicine und der neuen funktionalen Eliten in der Medizin aus system- und interaktionstheoretischer Perspektive. Zeitschrift für Soziologie 2002; 31: 294-315
- 101 Deutscher Bundestag. Kurzinformation. Medizinische Leitlinien. 2021 www.bundestag.de/resource/blob/876444/83593a354ba88614b34657f2ff82ed80/WD-9-094-21-pdf-data.pdf Stand: 11.09.2023
- 102 Allen D, Harkins KJ. Too much guidance?. Lancet 2005; 365: 1768
- 103 Arndt BG, Beasley JW, Watkinson MD. et al. Tethered to the EHR: Primary care physician workload assessment using EHR event log data and time-motion observations. Ann Fam Med 2027 15: 419-426
- 104 Delamothe T. Wanted: guidelines that doctors will follow. BMJ 1993; 307: 218
- 105 Ratnani I. Gap Between Practices of Evidence-based Medicine and Personalized. Medicine: A Barrier in Learning. In Fulfillment of the Requirements for the Degree of Doctor of Education. University of Houston. 2021
- 106 Feinstein AR, Massa RD. Problems in the ‚evidence‘ oft the ‚evidence based medicine‘. Am J Med 1997; 103: 529-535
- 107 Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003; 327: 1459-1461
- 108 Jones DS, Podolsky SH. The history and fate of the gold standard. Lancet 2015; 385: 1502-1503
- 109 Manfredini D, Greene CS, Ahlberg J. et al. Evidence-based dentistry or meta-analysis illness? A commentary on current publishing trends in the field of temporomandibular disorders and bruxism. J Oral Rehabil 2019; 46: 1-4
- 110 Silva V, Grande AJ, Martimbianco AL. et al. Overview of systematic reviews – a new type of study: part I: why and for whom?. Sao Paulo Med J 2012; 130: 398-404
- 111 Barron BA, Bukantz SC. The evaluation of new drugs. Current Food and drug Administration regulations and statistical aspects of clinical trials. Arch Intern Med 1967; 119: 547-556
- 112 Revicki DA, Frank L. Pharmacoeconomic evaluation in the real world. Effectiveness versus efficacy studies. Pharmacoeconomics 1999; 15: 423-434
- 113 Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcare interventions is evolving. BMJ 1999; 319: 652-653
- 114 Schneeweiss S. Von Real-World-Daten zur Real-World-Evidenz: eine praktische Anleitung. Präv Gesundheitsf 2023;
- 115 Benbow JH, Rivera DR, Lund JL. et al. Increasing Inclusiveness of Patient-Centric Clinical Evidence Generation in Oncology: Real-World Data and Clinical Trials. Am Soc Clin Oncol Educ Book 2022; 42: 1-11
- 116 Liu F, Panagiotakos D. Real-world data: a brief review of the methods, applications, challenges and opportunities. BMC Med Res Methodol 2022; 22: 287
- 117 Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet 2017; 390: 415-423
- 118 Meerpohl J. „. Evidenz gibt es immer!“ – Interview mit Jörg Meerpohl. Wissen was wirkt 2022. https://wissenwaswirkt.org/evidenz-gibt-es-immer Stand: 11.09.2023
- 119 Gelman A. The Problems with p-values are not just with p-values. The American Statistician, Online Discussion 2016. https://stat.columbia.edu/~gelman/research/published/asa_pvalues.pdf Stand: 11.09.2023
- 120 Amrhein V, Trafimow D, Greenland S. Inferential Statistics as Descriptive Statistics: There Is No Replication Crisis If We Don’t Expect Replication. The American Statistician 2019; 73: 262-270
- 121 Calin-Jageman R, Cumming G. The New Statistics for Better Science: Ask How Much, How Uncertain, and What Else Is Known. The American Statistician 2019; 73: 270-280
- 122 Eichler M, Pokora R, Schwentner L. et al. Evidenzbasierte Medizin: Möglichkeiten und Grenzen. Dtsch Arztebl 2015; 112: A-2190-2192
- 123 Mulrow CD, Thacker SB, Pugh JA. A proposal for more informative abstracts of review articles. Ann Intern Med 1988; 108: 613-615
- 124 Greenhalgh T, Thorne S, Malterud K. Time to challenge the spurious hierarchy of systematic over narrative reviews? . Eur J Clin Invest 2018; 48: e 12931
- 125 Boell SK, Cecez-Kecmanovic D. A hermeneutic approach for conducting literature reviews and literature searches. CAIS 2014; 32: 257-286
- 126 Nevo I, Slonim-Nevo V. The myth of evidencebased practice: towards evidence-informed practice. Br J Soc Work 2011; 416: 1176-1197
- 127 Bastian H, Glasziou P, Chalmers I. Seventy-Five Trials and Eleven Systematic Reviews a Day: How Will We Ever Keep Up?. PLoS Med 2010; 7: e1000326
- 128 Miles A. Science, humanism, judgement, ethics: person-centered medicine as an emergent model of modern clinical practice. Folia Medica (Plovdiv) 2013; 55: 5-24
- 129 Miles A. On a medicine of the whole person: away from scientistic reductionism and towards the embrace of the complex in clinical practice. J Eval Clin Pract 2009; 15: 941-949
- 130 Miles A, Loughlin M. Models in the balance: evidence-based medicine versus evidence-informed individualized care. J Eval Clin Pract 2011; 17: 531-536
- 131 Mezzich J, Snaedal J, van Weel C, Heath I. Toward person-centered medicine: from disease to patient to person. Mt Sinai J Med 2010; 77: 304-306
- 132 World Health Organisation (WHO). Global Status Report on Non-communicable Diseases https://apps.who.int/iris/bitstream/handle/10665/44579/9789240686458_eng.pdf Stand: 11.09.2023
- 133 Dubois CA, Singh D, Jiwani I. The human resource challenge in chronic care. In: Nolte E, Mckee CM, Hrsg. Caring for people with chronic conditions. A health system perspective. Berkshire: Open University Press; 2008
- 134 Van Royen P, Beyer M, Chevallier P. et al. The research agenda for general practice/family medicine and primary health care in Europe. Part 3. Results: person centred care, comprehensive and holistic approach. Eur J Gen Pract 2010; 16: 113-119
- 135 Bieber C, Gschwendtner K, Müller N. et al. Partizipative Entscheidungsfindung (PEF) – Patient und Arzt als Team. Psychother Psych Med 2016; 66: 195-207
- 136 Pressemitteilung IQWiG vom 06.09.2023. Führt eine gemeinsame Entscheidungsfindung von Ärztin und Patient zu besseren Behandlungsergebnissen? Vorläufiger ThemenCheck-Bericht zeigt keine Vorteile für Gesundheitszustand oder Lebensqualität www.iqwig.de/presse/pressemitteilungen/pressemitteilungen-detailseite_100418.html Stand: 12.09.2023
- 137 Grebe I. Shared Decision Making. CME 2023; 20: 48
- 138 Gesetz zur Verbesserung der Rechte von Patientinnen und Patienten Bundesgesetzblatt vom 25.02.2013, Teil I www.bundesaerztekammer.de/fileadmin/user_upload/_old-files/downloads/Patientenrechtegesetz_BGBl.pdf Stand: 12.09.2023
- 139 Wiesemann C. Vertrauen als moralische Praxis – Bedeutung für Ethik und Medizin. In: Steinfath H, Wiesemann C, Hrsg.: Autonomie und Vertrauen. Schlüsselbegriffe der modernen Medizin. Wiesbaden: Springer; 2016: 69-99
- 140 Beier K. Vertrauen in der Medizin. In: Schweer MKW, Hrsg. Facetten des Vertrauens und Misstrauens. Wiesbaden: Springer VS; 2022: 265-285
- 141 Fulford KW. Values-based practice: a new partner to evidence-based practice and a first for psychiatry?. Mens Sana Monogr 2008; 6: 10-21
- 142 Vogenberg FR, Isaacson Barash C, Pursel M. Personalized medicine: part 1: evolution and development into theranostics. P T 2010; 35 (10) 560-576
- 143 Chow N, Gallo L, Busse JW. Evidence-based medicine and precision medicine: Complementary approaches to clinical decision-making. Precis Clin Med 2018; 1: 60-64
- 144 Leplege A, Gzil F, Cammelli M. et al. Person-centredness: conceptual and historical perspectives. Disabil Rehabil 2007; 29: 1555-1515
- 145 Olsson LE, Karlsson J, Ekman I. The integrated care pathway reduced the number of hospital days by half: a prospective comparative study of patients with acute hip fracture. J Orthop Surg Res 2006; 1: 3
- 146 Ekman I, Swedberg K, Taft C. et al. Person-centered care--ready for prime time. Eur J Cardiovasc Nurs 2011; 10: 248-251